(Nasdaq: BDSX), a leading diagnostics solutions company, announced the publication of the largest lung nodule biomarker clinical validation study ever conducted. This milestone strengthens the ...

Imagine you go to the healthcare provider because you have a bad cough, or maybe you fell and hurt your ribs.

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...

The biopsy came back positive. It’s lung cancer.” Countless people in our community hear these words no one ever expects.

It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung cancers occur in people without a history of smoking. While smoking remains the ...

According to the American Cancer Society, lung cancer is the deadliest cancer in the United States and the second most common type of cancer. A promising new approach could change that: advanced ...

In 2023, lung cancer was a brutal killer in Louisiana, making up about 27% of Louisiana's total cancer deaths. That amounts to more than 2,300 lives lost every year from lung cancer, according to the ...

Study to evaluate clinical performance of CyPath® Lung for the early detection of lung cancer in high-risk patientsMurtha Cancer Center Research Program at Uniformed Services University of the Health ...

The US Food and Drug Administration (FDA) has cleared a lung cancer detection tool on Median Technologies’ eyonis, a suite of artificial intelligence (AI)-based software for early cancer diagnosis.

Biodesix (NASDAQ:BDSX) outlined its current commercial focus, growth priorities, and financial milestones during a ...

U.S. Air Force firefighters from the 7th Civil Engineer Squadron participate in live fire training exercise April 2, 2014, at Dyess Air Force Base, Texas. Teams from the Dyess Fire Department and ...